 NEW YORK, March 31, 2021 GLOBE NEWSWIRE -- Delcath Systems, Inc. NASDAQ: DCTH, an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today reported business highlights and financial results for the fourth quarter ended December 31, 2020, and earlier today reported preliminary topline data. The company will host its quarterly call at 8:00am ET today, with a primary focus on discussing the preliminary top line data. 